SEC Form D · filed August 19, 2015
Kala Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Mark Iwicki · Waltham, MAExec · DirectorRajeev B. Shah · Waltham, MADirectorHongming B. Chen · Waltham, MAExecKim Brazzell · Waltham, MAExecHoward B. Rosen · Waltham, MADirectorCharles B. Mcdermott · Waltham, MAExecRobert Langer · Waltham, MADirectorRobert Tepper · Waltham, MADirectorRobert Paull · Waltham, MADirectorKevin Bitterman · Waltham, MADirectorDarren J. Kottle · San Francisco, CAExecBernard I. Luskin · LOS ANGELES, CAExecKim I. Halvorsen · LOS ANGELES, CADirectorDavid L. Rensink · SIOUX FALLS, SDDirectorMichael I. Iscove · LOS ANGELES, CADirectorKaren Wagner · Waltham, MADirectorAdam Mendelsohn · Emeryville, CAExec · DirectorKathleen Fischer · Emeryville, CAExec · DirectorW. D. Baker · Emeryville, CADirectorAaron Mendelsohn · Emeryville, CADirectorLily Peng · Emeryville, CAExecKarey Barker · Salt Lake City, UTDirectorTyler Christenson · Salt Lake City, UTExec · DirectorPeter Jarman · Salt Lake City, UTDirectorJoseph M. Stanford · Brandon, SDDirectorSidhartha Singh · New York, NYExecKaren Wagner · Waltham, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗